US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NephroGenex, Inc.

0.1401

+0.0000

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:0.1401

Open:0.1401

Low:0.1401

Close:0.1401

Loading ...

Overview Company News Filings

NRx Pharmaceuticals Reports Minutes of Recent U.S. Food and Drug Administration (FDA) Meeting on the Development of NRX-101 to Treat Severe Bipolar Depression in Patients with Suicidality

NRX Pharmaceuticals Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

BRIEF-NRx Pharmaceuticals Reports Recommendations Of Data Safety Monitoring Board For Trial Of NRX-101

NRx Pharmaceuticals Reports Recommendations of Data Safety Monitoring Board for Trial of NRX-101 in Patients with Severe Bipolar Depression and Subacute Suicidal Ideation or Behavior

NRx Pharmaceuticals Provides Progress Update on Interactions with the FDA regarding Path to NDA Submission for NRX-101

Noronex (ASX:NRX) launches diamond drilling program at Snowball, Namibia

The Market Herald

Noronex (ASX:NRX) raising $1.5m for Namibia exploration

The Market Herald

Noronex Receives Commitments To Raise A$1.5M

NRX Pharmaceuticals Q3 EPS $(0.14), Inline

NRx Pharmaceuticals Produces First Phase 3-stage NRX-101 Drug Made Using Commercial Process

Noronex (ASX:NRX) reports encouraging copper results from Daheim, Namibia

The Market Herald

BRIEF-Relief Therapeutics And NRX Announce Tentative Settlement Of Pending Litigation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRX\",,,,,undefined,":{"symbol":"NRX","market":"US","secType":"STK","nameCN":"NephroGenex, Inc.","latestPrice":0.1401,"timestamp":1463083200000,"preClose":0.1401,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Pre-Mkt","change":0,"latestTime":"04-29 09:19:10 EDT","open":0.1401,"high":0.1401,"low":0.1401,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745933400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1401,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRX\",,,,,undefined,":{"symbol":"NRX","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.1401,"amplitude":0,"preClose":0.1401,"low":0.1401,"week52Low":0.101,"pbRate":"--","week52High":8.9,"institutionHeld":0,"latestPrice":0.1401,"eps":0,"divideRate":0,"volume":0,"delay":0,"open":0.1401},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2311920885","title":"NRx Pharmaceuticals Reports Minutes of Recent U.S. Food and Drug Administration (FDA) Meeting on the Development of NRX-101 to Treat Severe Bipolar Depression in Patients with Suicidality","url":"https://stock-news.laohu8.com/highlight/detail?id=2311920885","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2311920885?lang=en_us&edition=fundamental","pubTime":"2023-02-13 19:47","pubTimestamp":1676288820,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MLJkaeU2eWLAg2.ZA4Qcqw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MLJkaeU2eWLAg2.ZA4Qcqw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-reports-minutes-recent-114700096.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-reports-minutes-recent-114700096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NRX","NRXP","NRXPW"],"gpt_icon":0},{"id":"2308075354","title":"NRX Pharmaceuticals Price Target Maintained With a $2.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2308075354","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2308075354?lang=en_us&edition=fundamental","pubTime":"2023-02-03 01:27","pubTimestamp":1675358820,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4114","TGT","BK4533","NRXP","LU1244550577.SGD","LU1244550221.USD","BK4532","LU1244550494.USD","BK4585","BK4007","NRX","LU0823411888.USD","BK4504"],"gpt_icon":0},{"id":"2308042423","title":"BRIEF-NRx Pharmaceuticals Reports Recommendations Of Data Safety Monitoring Board For Trial Of NRX-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2308042423","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2308042423?lang=en_us&edition=fundamental","pubTime":"2023-02-02 19:54","pubTimestamp":1675338882,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRX","NRXP","BK4007"],"gpt_icon":0},{"id":"2308717042","title":"NRx Pharmaceuticals Reports Recommendations of Data Safety Monitoring Board for Trial of NRX-101 in Patients with Severe Bipolar Depression and Subacute Suicidal Ideation or Behavior","url":"https://stock-news.laohu8.com/highlight/detail?id=2308717042","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2308717042?lang=en_us&edition=fundamental","pubTime":"2023-02-02 19:47","pubTimestamp":1675338420,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MLJkaeU2eWLAg2.ZA4Qcqw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MLJkaeU2eWLAg2.ZA4Qcqw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-reports-recommendations-data-114700485.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-reports-recommendations-data-114700485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NRXP","NRX","BK4007","NRXPW"],"gpt_icon":0},{"id":"2304643298","title":"NRx Pharmaceuticals Provides Progress Update on Interactions with the FDA regarding Path to NDA Submission for NRX-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2304643298","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2304643298?lang=en_us&edition=fundamental","pubTime":"2023-01-19 19:47","pubTimestamp":1674128820,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MLJkaeU2eWLAg2.ZA4Qcqw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MLJkaeU2eWLAg2.ZA4Qcqw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-provides-progress-interactions-114700377.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-provides-progress-interactions-114700377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NRXPW","NRXP","LU2065732104.USD","PRGS","NRX","BK4097"],"gpt_icon":0},{"id":"2291113720","title":"Noronex (ASX:NRX) launches diamond drilling program at Snowball, Namibia","url":"https://stock-news.laohu8.com/highlight/detail?id=2291113720","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2291113720?lang=en_us&edition=fundamental","pubTime":"2022-12-16 09:03","pubTimestamp":1671152580,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketherald.com.au/noronex-asxnrx-launches-diamond-drilling-program-at-snowball-namibia-2022-12-16/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["NRX.AU","BK7039","XAO.AU","XJO.AU","BK4526","ASX","ASX.AU","BK7110","XKO.AU","BK4141","NRX"],"gpt_icon":0},{"id":"2284012745","title":"Noronex (ASX:NRX) raising $1.5m for Namibia exploration","url":"https://stock-news.laohu8.com/highlight/detail?id=2284012745","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2284012745?lang=en_us&edition=fundamental","pubTime":"2022-11-18 11:20","pubTimestamp":1668741600,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketherald.com.au/noronex-asxnrx-raising-1-5m-for-namibia-exploration-2022-11-18/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["ASX","BK4141","ASX.AU","NRX","BK7110","XKO.AU","BK7039","BK4526","NRX.AU","XAO.AU","XJO.AU"],"gpt_icon":0},{"id":"2284743124","title":"Noronex Receives Commitments To Raise A$1.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2284743124","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2284743124?lang=en_us&edition=fundamental","pubTime":"2022-11-18 09:24","pubTimestamp":1668734656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRX"],"gpt_icon":0},{"id":"2283030024","title":"NRX Pharmaceuticals Q3 EPS $(0.14), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2283030024","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2283030024?lang=en_us&edition=fundamental","pubTime":"2022-11-14 20:47","pubTimestamp":1668430078,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 65 percent increase over losses of $(0.40) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/22/11/29696156/nrx-pharmaceuticals-q3-eps-0-14-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","NRX"],"gpt_icon":0},{"id":"2282519903","title":"NRx Pharmaceuticals Produces First Phase 3-stage NRX-101 Drug Made Using Commercial Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2282519903","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2282519903?lang=en_us&edition=fundamental","pubTime":"2022-11-09 19:47","pubTimestamp":1667994420,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MLJkaeU2eWLAg2.ZA4Qcqw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MLJkaeU2eWLAg2.ZA4Qcqw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-produces-first-phase-114700624.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-produces-first-phase-114700624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NRXP","NRXPW","NRX"],"gpt_icon":0},{"id":"2263145394","title":"Noronex (ASX:NRX) reports encouraging copper results from Daheim, Namibia","url":"https://stock-news.laohu8.com/highlight/detail?id=2263145394","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2263145394?lang=en_us&edition=fundamental","pubTime":"2022-08-29 10:24","pubTimestamp":1661739840,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketherald.com.au/noronex-asxnrx-report-encouraging-copper-results-from-daheim-namibia-2022-08-29/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7039","NRX","BK4526","BK4141","XJO.AU","BK7110","NRX.AU","XAO.AU","ASX","ASX.AU","XKO.AU"],"gpt_icon":0},{"id":"2261031545","title":"BRIEF-Relief Therapeutics And NRX Announce Tentative Settlement Of Pending Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2261031545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2261031545?lang=en_us&edition=fundamental","pubTime":"2022-08-22 18:58","pubTimestamp":1661165912,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRX","NRXP"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-02-24","symbol":"NRX","expectedEps":-0.52,"name":"NephroGenex Inc","time":"Post Market","type":"earning","dateTimestamp":1456290000000,"reportTimeType":"post"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRX\",market:\"US\",delay:false,,,undefined,":{}}}